Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: November 2022

Workgroups: Access to Health Services Workgroup

The U.S. Preventive Services Task Force (USPSTF) recommends against using combined estrogen and progestin to prevent chronic conditions in postmenopausal people. For people who have gone through menopause and had a hysterectomy, USPSTF recommends against using estrogen alone to prevent chronic conditions. USPSTF has made other recommendations to prevent chronic conditions in adults, which include:

Read more about this resource

Objectives related to this resource (1)

Increase the proportion of adults who get recommended evidence-based preventive health care — AHS‑08
Getting worse

Suggested Citation

1.

U.S. Preventive Services Task Force. (2022). Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication.